Interleukin (IL)-39 [IL-23p19/Epstein–Barr virus-induced 3 (Ebi3)] induces differentiation/expansion of neutrophils in lupus-prone mice

Clinical and Experimental Immunology

Volumn 186, Issue 2, 2016, Pages 144-156

  Wang, X ^a   Liu, X ^a,b   Zhang, Y ^a,c   Wang, Z ^a,d   Zhu, G ^a,c   Han, G ^a   Chen, G ^a   Hou, C ^a   Wang, T ^c   Ma, N ^e   Shen, B ^a   Li, Y ^a   Xiao, H ^a   Wang, R ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b Beijing 307 Hospital   (China)

^c HENAN UNIVERSITY   (China)

^d JILIN UNIVERSITY   (China)

^e THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

autoimmune diseases; BAFF; IL 39; lupus; neutrophils

Indexed keywords

B CELL ACTIVATING FACTOR; CD11B ANTIGEN; CD19 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; INTERLEUKIN 12; INTERLEUKIN 23P19; INTERLEUKIN 39; PROTEIN P19; SYNDECAN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE RELEASE; EPSTEIN BARR VIRUS; FEMALE; GLOMERULAR STRUCTURE; HEMATOPOIETIC CELL; HOMOZYGOTE; IN VITRO STUDY; IN VIVO STUDY; LUPUS VULGARIS; LYMPHOID CELL; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; UPREGULATION;

EID: 85027933866     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12840     Document Type: Article

References (49)

1. Mills JA. Systemic lupus erythematosus. N Engl J Med 1994; 330:1871–9.
2. Perry D, Sang A, Yin Y, Zheng YY, Morel L. Murine models of systemic lupus erythematosus. J Biomed Biotechnol 2011; 2011:271694.
3. Theofilopoulos AN, Dixon FJ. Murine models of systemic lupus erythematosus. Adv Immunol 1985; 37:269–390.
4. Gualtierotti R, Biggioggero M, Penatti AE, Meroni PL. Updating on the pathogenesis of systemic lupus erythematosus. Autoimmun Rev 2010; 10:3–7.
5. Ramnath D, Tunny K, Hohenhaus DM et al. TLR3 drives IRF6-dependent IL-23p19 expression and p19/EBI3 heterodimer formation in keratinocytes. Immunol Cell Biol 2015; 93:771.
6. Wang X, Wei Y, Xiao H et al. A novel IL-23p19/Ebi3 (IL-39) cytokine mediates inflammation in lupus-like mice. Eur J Immunol 2016; 46:1343–50.
7. Sun L, He C, Nair L, Yeung J, Egwuagu CE. Interleukin 12 (IL-12) family cytokines: role in immune pathogenesis and treatment of CNS autoimmune disease. Cytokine 2015; 75:249–55.
8. Shen P, Roch T, Lampropoulou V et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 2014; 507:366–70.
9. Wang RX, Yu CR, Dambuza IM et al. Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat Med 2014; 20:633–41.
10. Du J, Li Z, Shi J, Bi L. Associations between serum interleukin-23 levels and clinical characteristics in patients with systemic lupus erythematosus. J Int Med Res 2014; 42:1123–30.
11. Xia LP, Li BF, Shen H, Lu J. Interleukin-27 and interleukin-23 in patients with systemic lupus erythematosus: possible role in lupus nephritis. Scand J Rheumatol 2015; 44:200–5.
12. Mok MY, Wu HJ, Lo Y, Lau CS. The relation of interleukin 17 (IL-17) and IL-23 to Th1/Th2 cytokines and disease activity in systemic lupus erythematosus. J Rheumatol 2010; 37:2046–52.
13. Qiu F, Song L, Yang N, Li X. Glucocorticoid downregulates expression of IL-12 family cytokines in systemic lupus erythematosus patients. Lupus 2013; 22:1011–6.
14. Smith S, Gabhann JN, Higgs R et al. Enhanced interferon regulatory factor 3 binding to the interleukin-23p19 promoter correlates with enhanced interleukin-23 expression in systemic lupus erythematosus. Arthritis Rheum 2012; 64:1601–9.
15. Vignali DA, Kuchroo VK. IL-12 family cytokines: immunological playmakers. Nat Immunol 2012; 13:722–8.
16. Kastelein RA, Hunter CA, Cua DJ. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu Rev Immunol 2007; 25:242.
17. Flores RR, Kim E, Zhou L et al. IL-Y, a synthetic member of the IL-12 cytokine family, suppresses the development of type 1 diabetes in NOD mice. Eur J Immunol 2015; 45:3114–25.
18. Egwuagu CE, Yu CR, Sun L, Wang R. Interleukin 35: critical regulator of immunity and lymphocyte-mediated diseases. Cytokine Growth Factor Rev 2015; 26:587–93.
19. Wang RX, Yu CR, Mahdi RM, Egwuagu CE. Novel IL27p28/IL12p40 cytokine suppressed experimental autoimmune uveitis by inhibiting autoreactive Th1/Th17 cells and promoting expansion of regulatory T cells. J Biol Chem 2012; 287:36012–21.
20. Trinchieri G, Pflanz S, Kastelein RA. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 2003; 19:641–4.
21. Kaplan MJ. Neutrophils in the pathogenesis and manifestations of SLE. Nat Rev Rheumatol 2011; 7:691–9.
22. Smith CK, Kaplan MJ. The role of neutrophils in the pathogenesis of systemic lupus erythematosus. Curr Opin Rheumatol 2015; 27:448–53.
23. Furukawa F. Animal models of cutaneous lupus erythematosus and lupus erythematosus photosensitivity. Lupus 1997; 6:193–202.
24. Vincent FB, Morand EF, Mackay F. BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus. Immunol Cell Biol 2012; 90:293–303.
25. + regulatory B cells in immune homeostasis. J Leukocyte Biol 2015; 97:547–56.
26. Ma N, Liu X, Xing C et al. Ligation of metabotropic glutamate receptor 3 (Grm3) ameliorates lupus-like disease by reducing B cells. Clin Immunol 2015; 160:142–54.
27. Ma N, Xing C, Xiao H et al. BAFF suppresses IL-15 expression in B cells. J Immunol 2014; 192:4192–201.
28. Cohen PL, Eisenberg RA. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 1991; 9:243–69.
29. – Breg cells are expanded during inflammation and in mice with lupus-like disease. Mol Immunol 2016; 71:54–63.
30. Cervenak L, Magyar A, Boja R, Laszlo G. Differential expression of GL7 activation antigen on bone marrow B cell subpopulations and peripheral B cells. Immunol Lett 2001; 78:89–96.
31. Zheng M, Xing C, Xiao H et al. Interaction of CD5 and CD72 is involved in regulatory T and B cell homeostasis. Immunol Invest 2014; 43:705–16.
32. Mackay F, Woodcock SA, Lawton P et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 1999; 190:1697–710.
33. Khare SD, Sarosi I, Xia XZ et al. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc Natl Acad Sci USA 2000; 97:3370–5.
34. Gross JA, Johnston J, Mudri S et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 2000; 404:995–9.
35. Mackay F, Schneider P. Cracking the BAFF code. Nat Rev Immunol 2009; 9:491–502.
36. Fairfax KA, Corcoran LM, Pridans C et al. Different kinetics of Blimp-1 induction in B cell subsets revealed by reporter gene. J Immunol 2007; 178:4104–11.
37. Klein U, Dalla-Favera R. Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol 2008; 8:22–33.
38. Nieuwenhuis EE, Neurath MF, Corazza N et al. Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice. Proc Natl Acad Sci USA 2002; 99:16951–6.
39. Tong H, Miyazaki Y, Yamazaki M et al. Exacerbation of delayed-type hypersensitivity responses in EBV-induced gene-3 (EBI-3)-deficient mice. Immunol Lett 2010; 128:108–15.
40. Igawa T, Nakashima H, Sadanaga A et al. Deficiency in EBV-induced gene 3 (EBI3) in MRL/lpr mice results in pathological alteration of autoimmune glomerulonephritis and sialadenitis. Mod Rheumatol 2009; 19:33–41.
41. Kim BJ, Lee S, Berg RE, Simecka JW, Jones HP. Interleukin-23 (IL-23) deficiency disrupts Th17 and Th1-related defenses against Streptococcus pneumoniae infection. Cytokine 2013; 64:375–81.
42. Redell MS, Tsimelzon A, Hilsenbeck SG, Tweardy DJ. Conditional overexpression of Stat3alpha in differentiating myeloid cells results in neutrophil expansion and induces a distinct, antiapoptotic and pro-oncogenic gene expression pattern. J Leukoc Biol 2007; 82:975–85.
43. Rodrigues DR, Fernandes RK, Balderramas Hde A et al. Interferon-gamma production by human neutrophils upon stimulation by IL-12, IL-15 and IL-18 and challenge with Paracoccidioides brasiliensis. Cytokine 2014; 69:102–9.
44. Taylor PR, Roy S, Leal SM Jr et al. Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORγt and dectin-2. Nat Immunol 2014; 15:143–51.
45. Li JP, Wu H, Xing W et al. Interleukin-27 as a negative regulator of human neutrophil function. Scand J Immunol 2010; 72:284–92.
46. Wang Z, Liu JQ, Liu Z et al. Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis. J Immunol 2013; 190:2415–23.
47. Coquery CM, Wade NS, Loo WM et al. Neutrophils contribute to excess serum BAFF levels and promote CD4+ T cell and B cell responses in lupus-prone mice. PLOS ONE 2014; 9:e102284.
48. Yanaba K, Bouaziz ZD, Matsushita T, Magro CM, St Clair EW, Tedder TF. B-lymphocyte contributions to human autoimmune disease. Immunol Rev 2008; 223:284–99.
49. De S, Barnes BJ. B cell transcription factors: potential new therapeutic targets for SLE. Clin Immunol 2014; 152:140–51.